Surprising GLP-1 side effects Commenting on which newly identified symptoms were the most surprising, Neil Sehgal, ME, MS, the studys first author and a doctoral student advised by Guntuku and Lyle Ungar, PhD, told Medical News Today :\ There were a few interesting findings
This is one way some people try to get better weight loss results
10.1016/j.tips.2023.07.007 90 RyanS
Conclusions This real-world health economic evaluation along with a comprehensive systematic review suggest that the use of a GLP-1RA versus insulin has a high likelihood of being cost-effective for T2D patients who require intensified injection therapy from a third-party payer, healthcare sector, and societal perspectives
Could reduced food intake place me at risk for a nutritional deficiency
No longterm human trials exist